XML 57 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
NET INCOME (LOSS) PER SHARE (Tables)
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Schedule of computation of net (loss) income per share
The computation of Net income (loss) per share is as follows (in thousands, except per share amounts):
Three Months Ended March 31,
20242023
Basic Net income (loss) per share:
Numerator
Net income (loss)$1,176,245 $(78,896)
Less: Income allocated to participating securities(766)— 
Net income (loss) attributable to common stockholders, basic$1,175,479 $(78,896)
Denominator
Weighted-average shares of common stock used to compute Net income (loss) per share attributable to common stockholders, basic242,793 231,489 
Net income (loss) per share attributable to common stockholders, basic$4.84 $(0.34)
Diluted Net income (loss) per share:
Numerator
Net income (loss)$1,176,245 $(78,896)
Less: Income allocated to participating securities(697)— 
Add: Interest on convertible notes, net of tax2,531 — 
Net income (loss) attributable to common stockholders, diluted
$1,178,079 $(78,896)
Denominator
Weighted-average shares of common stock used to compute Net income (loss) per share attributable to common stockholders, basic242,793 231,489 
Weighted-average effect of potentially dilutive securities:
Stock options18,534 — 
Convertible notes4,145 — 
RSUs2,164 — 
Restricted common stock309 — 
Weighted-average shares of common stock used to compute Net income (loss) per share attributable to common stockholders, diluted267,945 231,489 
Net income (loss) per share attributable to common stockholders, diluted$4.40 $(0.34)
Schedule of potentially dilutive shares
The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive (in thousands):
March 31,
2024 2023
Stock options6,671 31,274 
ESPP733 822 
PRSUs322 — 
RSUs292 10,592 
Restricted common stock242 1,004 
Convertible notes— 3,880 
Contingent consideration— 76 
Total8,260 47,648